Search Results
May 12, 2026, 18:01 ET Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
provider.Do not use Foundayo if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).Do not use Foundayo if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).Do not use Foundayo if you have had a serious
More news about: Eli Lilly and Company
May 07, 2026, 07:00 ET Wegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026
tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine
More news about: Novo Nordisk
May 06, 2026, 09:00 ET Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility
provider. Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC). Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use Zepbound if you have had a serious
More news about: Eli Lilly and Company
May 05, 2026, 20:28 ET MingMed Biotechnology presenta datos positivos de QA102 oral para la degeneración macular asociada a la edad
macular asociada a la edad (DMAE) incluye dos candidatos novedosos: QA102, una nueva entidad química (NCE), y QA108, un medicamento tradicional chino (MTC).
More news about: MingMed Biotechnology Co., Ltd
May 01, 2026, 08:04 ET Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US
thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Ozempic® if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia
More news about: Novo Nordisk
Apr 30, 2026, 08:57 ET Members Trust Company Named 2026 CUSO of the Year by National Association of Credit Union Service Organizations
TAMPA, Fla., April 30, 2026 /PRNewswire/ -- Members Trust Company (MTC), the nation's first chartered trust and investment management company wholly owned by credit unions, today announced it has been named 2026 CUSO of the
More news about: Members Trust Company
Apr 30, 2026, 08:01 ET Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool
positives were reported in this study99mTc-maraciclatide imaging was able to detect lesions across all endometriosis subtypes supporting the applicability of the scan to various patient groups99mTc-maraciclatide was well tolerated and patient acceptability was highDavid
More news about: Serac Healthcare Limited
Apr 30, 2026, 07:00 ET GameAbove Golf Among Lead Investors in McLaren Golf, Expands Strategic Position in the Global Premium Golf Equipment Market
golf equipment company built on the engineering DNA of McLaren Racing and McLaren Automotive.With operations at the McLaren Technology Centre (MTC) in Woking, England and in Carlsbad, California — a global hub for golf equipment design, engineering and development — McLaren Golf brings together
More news about: GameAbove
Apr 28, 2026, 12:27 ET FuturHealth Among the First to Offer Eli Lilly's Oral GLP-1, Orforglipron, Expanding Access to Next-Generation, Non-Injectable Treatment
Information: Foundayo™ is a prescription medication with important risks, including a boxed warning for thyroid C-cell tumors. Not for patients with MTC or MEN 2. See full Prescribing Information at
More news about: FuturHealth
Apr 27, 2026, 11:59 ET STULZ USA and President, Brian Hatmaker, Nominated for Maryland Tech Council ICON Awards
solutions for mission-critical applications, is proud to announce that both the company and its President have been nominated for the Maryland Tech Council (MTC) ICON Awards.
More news about: STULZ Air Technology Systems, Inc.
Apr 23, 2026, 08:35 ET Exclusive Underwriting Managers Shatter Trucking Industry Delays with Empowered Underwriting and Same-Day Service
Underwriter (MGU) specializing in commercial transportation, has announced a series of enhancements to its Physical Damage (APD) and Motor Truck Cargo (MTC) program. The initiative aims to address chronic delays in the trucking insurance sector by shifting away from rigid wholesale models in favor of human-led,
More news about: Exclusive Underwriting Managers
Apr 21, 2026, 20:53 ET Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting
led by MSD.About A400/EP0031A400/EP0031 novel next-generation selective RET inhibitor for NSCLC, medullary thyroid cancer (MTC) and other solid tumors with a high prevalence of RET alterations. The NDA of A400/EP0031 has been accepted for review by the Center for Drug Evaluation
More news about: Kelun-Biotech
Apr 16, 2026, 19:00 ET Bay Area Bike Champions Named for 2026
her contagious energy in getting more kids on bikes.MTC will recognize all 2026 winners at its meeting on Wednesday, May 27, both in person and virtually. Each honoree will receive an engraved plaque, a signed MTC certificate, and prizes from Sports Basement and Mike's Bikes.Full
More news about: Metropolitan Transportation Commission
Apr 16, 2026, 06:45 ET ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
provider.Do not use Foundayo if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).Do not use Foundayo if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).Do not use Foundayo if you have had a serious
More news about: Eli Lilly and Company
Apr 15, 2026, 08:21 ET Shed Adds Foundayo™ to Its Platform, Expanding Oral GLP-1 Access for Patients Nationwide
prescription medicine. It may cause thyroid tumors, including thyroid cancer. Do not use if you or a family member have ever had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, constipation, and vomiting. Foundayo
More news about: Shed
Apr 14, 2026, 14:01 ET Work to Start on I-580 Carpool Lane Extension in Oakland
SAN FRANCISCO, April 14, 2026 /PRNewswire/ -- The Metropolitan Transportation Commission (MTC) today announced that construction work will begin next week on a six-month project to convert the far-left lane of westbound Interstate 580 to a high-occupancy
More news about: Metropolitan Transportation Commission
Apr 14, 2026, 10:05 ET Study Reveals How Mice Can Quickly Identify Odors
endings.) These are in turn connected to batches of mitral and tufted cells (MTCs).The study authors found that the olfactory bulb glomeruli-MTC signals triggered within the first 50 milliseconds of the sniff cycle determined the type of odor that tested mice perceived. In the process of rapid
More news about: NYU Langone Health System
Apr 09, 2026, 06:45 ET Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
provider.Do not use Foundayo if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).Do not use Foundayo if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).Do not use Foundayo if you have had a serious
More news about: Eli Lilly and Company
Apr 07, 2026, 08:00 ET Novo Nordisk's Wegovy® HD available now nationwide
tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine
More news about: NOVO NORDISK INC.
Apr 02, 2026, 11:00 ET Marin-Sonoma Coordinated Transit Service (MASCOTS) Plan launches April 12, 2026
The plan was developed by the Metropolitan Transportation Commission (MTC), the Transportation Authority of Marin, the Sonoma County Transportation and Climate Authorities, the Sonoma-Marin Area Rail Transit District, the Golden
More news about: Metropolitan Transportation Commission
Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
Warning for possible thyroid tumors, including cancer and should not be used in those with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation, stomach (abdomen)
More news about: NOVO NORDISK INC.
Apr 02, 2026, 08:00 ET Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
Warning for possible thyroid tumors, including cancer and should not be used in those with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation, stomach (abdomen)
More news about: NOVO NORDISK INC.
Apr 01, 2026, 11:30 ET FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
provider.Do not use Foundayo if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).Do not use Foundayo if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).Do not use Foundayo if you have had a serious
More news about: Eli Lilly and Company
Mar 31, 2026, 07:46 ET Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in peopleDo not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine
More news about: Novo Nordisk
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
provider. Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC). Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use Zepbound if you have had a serious
More news about: Eli Lilly and Company